These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 22001347)

  • 1. SPARC oppositely regulates inflammation and fibrosis in bleomycin-induced lung damage.
    Sangaletti S; Tripodo C; Cappetti B; Casalini P; Chiodoni C; Piconese S; Santangelo A; Parenza M; Arioli I; Miotti S; Colombo MP
    Am J Pathol; 2011 Dec; 179(6):3000-10. PubMed ID: 22001347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collagen accumulation is decreased in SPARC-null mice with bleomycin-induced pulmonary fibrosis.
    Strandjord TP; Madtes DK; Weiss DJ; Sage EH
    Am J Physiol; 1999 Sep; 277(3):L628-35. PubMed ID: 10484471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bleomycin-induced pulmonary injury in mice deficient in SPARC.
    Savani RC; Zhou Z; Arguiri E; Wang S; Vu D; Howe CC; DeLisser HM
    Am J Physiol Lung Cell Mol Physiol; 2000 Oct; 279(4):L743-50. PubMed ID: 11000135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SPARC production by bone marrow-derived cells contributes to myocardial fibrosis in pressure overload.
    Riley HJ; Kelly RR; Van Laer AO; Neff LS; Dasgupta S; Baicu CF; McDonald LT; LaRue AC; Zile MR; Bradshaw AD
    Am J Physiol Heart Circ Physiol; 2021 Feb; 320(2):H604-H612. PubMed ID: 33306449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukocyte, rather than tumor-produced SPARC, determines stroma and collagen type IV deposition in mammary carcinoma.
    Sangaletti S; Stoppacciaro A; Guiducci C; Torrisi MR; Colombo MP
    J Exp Med; 2003 Nov; 198(10):1475-85. PubMed ID: 14610043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation of fibrosis in vitro and in vivo with SPARC siRNA.
    Wang JC; Lai S; Guo X; Zhang X; de Crombrugghe B; Sonnylal S; Arnett FC; Zhou X
    Arthritis Res Ther; 2010; 12(2):R60. PubMed ID: 20359365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of secreted protein acidic and rich in cysteine (SPARC) in cardiac repair and fibrosis: Does expression of SPARC by macrophages influence outcomes?
    Bradshaw AD
    J Mol Cell Cardiol; 2016 Apr; 93():156-61. PubMed ID: 26582465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased ADAMTS1 mediates SPARC-dependent collagen deposition in the aging myocardium.
    Toba H; de Castro Brás LE; Baicu CF; Zile MR; Lindsey ML; Bradshaw AD
    Am J Physiol Endocrinol Metab; 2016 Jun; 310(11):E1027-35. PubMed ID: 27143554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased macrophage-derived SPARC precedes collagen deposition in myocardial fibrosis.
    McDonald LT; Zile MR; Zhang Y; Van Laer AO; Baicu CF; Stroud RE; Jones JA; LaRue AC; Bradshaw AD
    Am J Physiol Heart Circ Physiol; 2018 Jul; 315(1):H92-H100. PubMed ID: 29522370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small interfering RNA inhibition of SPARC attenuates the profibrotic effect of transforming growth factor beta1 in cultured normal human fibroblasts.
    Zhou X; Tan FK; Guo X; Wallis D; Milewicz DM; Xue S; Arnett FC
    Arthritis Rheum; 2005 Jan; 52(1):257-61. PubMed ID: 15641096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective role of NKT cells and macrophage M2-driven phenotype in bleomycin-induced pulmonary fibrosis.
    Grabarz F; Aguiar CF; Correa-Costa M; Braga TT; Hyane MI; Andrade-Oliveira V; Landgraf MA; Câmara NOS
    Inflammopharmacology; 2018 Apr; 26(2):491-504. PubMed ID: 28779430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SPARC regulates TGF-beta1-dependent signaling in primary glomerular mesangial cells.
    Francki A; McClure TD; Brekken RA; Motamed K; Murri C; Wang T; Sage EH
    J Cell Biochem; 2004 Apr; 91(5):915-25. PubMed ID: 15034927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of SPARC results in increased cardiac rupture and dysfunction after acute myocardial infarction.
    Schellings MW; Vanhoutte D; Swinnen M; Cleutjens JP; Debets J; van Leeuwen RE; d'Hooge J; Van de Werf F; Carmeliet P; Pinto YM; Sage EH; Heymans S
    J Exp Med; 2009 Jan; 206(1):113-23. PubMed ID: 19103879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amelioration of diabetic nephropathy in SPARC-null mice.
    Taneda S; Pippin JW; Sage EH; Hudkins KL; Takeuchi Y; Couser WG; Alpers CE
    J Am Soc Nephrol; 2003 Apr; 14(4):968-80. PubMed ID: 12660331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced angiogenesis characteristic of SPARC-null mice disappears with age.
    Reed MJ; Bradshaw AD; Shaw M; Sadoun E; Han N; Ferara N; Funk S; Puolakkainen P; Sage EH
    J Cell Physiol; 2005 Sep; 204(3):800-7. PubMed ID: 15795937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the expression of a secreted acidic protein rich in cysteine (SPARC) in human fibroblasts by transforming growth factor beta. Comparison of transcriptional and post-transcriptional control with fibronectin and type I collagen.
    Wrana JL; Overall CM; Sodek J
    Eur J Biochem; 1991 Apr; 197(2):519-28. PubMed ID: 1709099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of epithelial-derived fibroblasts to bleomycin-induced lung fibrosis.
    Tanjore H; Xu XC; Polosukhin VV; Degryse AL; Li B; Han W; Sherrill TP; Plieth D; Neilson EG; Blackwell TS; Lawson WE
    Am J Respir Crit Care Med; 2009 Oct; 180(7):657-65. PubMed ID: 19556518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type I collagen-deficient Mov-13 mice do not retain SPARC in the extracellular matrix: implications for fibroblast function.
    Iruela-Arispe ML; Vernon RB; Wu H; Jaenisch R; Sage EH
    Dev Dyn; 1996 Oct; 207(2):171-83. PubMed ID: 8906420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGFβ signaling in lung epithelium regulates bleomycin-induced alveolar injury and fibroblast recruitment.
    Degryse AL; Tanjore H; Xu XC; Polosukhin VV; Jones BR; Boomershine CS; Ortiz C; Sherrill TP; McMahon FB; Gleaves LA; Blackwell TS; Lawson WE
    Am J Physiol Lung Cell Mol Physiol; 2011 Jun; 300(6):L887-97. PubMed ID: 21441353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of SMOC2 reduces bleomycin (BLM)-induced pulmonary fibrosis by inhibition of TGF-β1/SMADs pathway.
    Luo L; Wang CC; Song XP; Wang HM; Zhou H; Sun Y; Wang XK; Hou S; Pei FY
    Biomed Pharmacother; 2018 Sep; 105():841-847. PubMed ID: 30021376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.